FIXX - Homology Medicines EPS beats by $0.13 beats on revenue March, 12 2020 04:29 PM Homology Medicines Inc. Homology Medicines (NASDAQ:FIXX): Q4 GAAP EPS of -$0.55 beats by $0.13.Revenue of $0.56M (-53.3% Y/Y) beats by $0.11M.Press ReleaseMore news on: Homology Medicines, Inc., Earnings news and commentary, Healthcare stocks news,